MUTYH and neoplasm: Tumor mutational signatures provided evidence that germline variation in BRCA1, PALB2, RAD51C, MUTYH and NTHL1 can be (but is not always) associated with tumor mutational signatures consistent with a functional role of these genes in endometrial tumor development.